Honor their memory with a charitable gift.

Founded in 1914, the American Sexual Health Association (ASHA) promotes the sexual health of individuals, families and communities by advocating sound policies and practices and educating the public, professionals and policy makers, in order to foster healthy behaviors and relationships and prevent adverse sexual health outcomes.

The ALS Association Evergreen Chapter is a dedicated group of volunteers and staff that are working daily to ease the burdens of patients and families who have ALS (also known as Lou Gehrig's Disease). This fatal illness has no known cause or cure. A person who has ALS will slowly loose the ability to move and even speak or swallow. The Evergreen Chapter provides services to people living with ALS and their family members, and raises money for research to find the cure are our top priorities. We serve Washington, Idaho, Montana and Alaska.

The Multiple Sclerosis Association of America (MSAA) is a leading resource for the entire MS community, improving lives today through vital services and support.

The Vasculitis Foundation supports and empowers our community through education, awareness and research.

The mission of the ALS Hope Foundation is to provide long-term support to: basic and clinical research programs leading to a cure, clinical centers of excellence for the care and treatment of people with ALS, support programs for people with ALS and their caregivers that optimize care and promote independence, and programs that promote education for people with ALS and physicians about diagnosis, treatment, and care.

UMDF's mission is to promote research and education for the diagnosis, treatment and cure of mitochondrial disorders and provide support to affected individuals and families.

The mission of Southeastern Guide Dogs is to create and nurture a partnership between a visually impaired individual and a guide dog, facilitating life's journey with mobility, independence and dignity.

Supporting patients and families while promoting research, education and awareness.

Clearbrook is committed to being a leader in creating innovative opportunities, services and supports for people with disabilities. We serve people over a range of ages and disabilities from children diagnosed with developmental delays at birth to the unique needs of seniors with disabilities and all ages in between. Annually, we support over 8,000 individuals as well as their families in 15 counties, in over 160 communities and 50 locations throughout Chicago, the suburbs, and northern Illinois. We are proud to be the largest provider of home-based services in Illinois.

Our mission is to find a effective treatments and ultimately a cure for fragile X syndrome, the most common inherited cause of autism. We directly fund research grants and fellowships at top universities around the world. FRAXA was founded in 1994 by three parents of children with fragile X. Fragile X Syndrome is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4000 boys and 1 in 6000 girls worldwide, and one in 260 women and 1 in 800 men are carriers. Treatments for fragile X are likely to help people affected by related disorders including autism, Alzheimers, and many other brain disorders.

At the Fanconi Cancer Foundation (FCF), we are committed to the advancement of FA research in an unwavering pursuit for better treatments, and ultimately a cure, for FA and FA-associated cancers. We offer support, education, and resources to families facing FA to help foster hope across the globe.

Since 1970, the OI Foundation has doubled funding for research every five years, for a total investment of more than $3.3 million. Funding is available for postdoctoral fellowships to encourage new investigators to begin a career in OI research, and seed grants for preliminary research. All applications are reviewed by the Foundation's Scientific Review Committee, which includes many preeminent OI researchers and clinicians. Funding also supports the OI Registry and the Linked Clinical Research Centers. The potential for results in OI research is growing, with recent advances in gene therapy, a new diagnostic test, and drug therapies under study.